Insys Therapeutics Inc (INSY:NASDAQ) Annual Reports & Investor Relations Material

Overview

Insys Therapeutics is a specialty pharmaceutical company with a focus on supportive care products. The opioid-tolerant cancer patients market Subsys, a fentanyl spray for breakthrough cancer pain, while the Dronabinol SG Capsule is a generic equivalent to Marinol for the treatment of chemotherapy-induced nausea, vomiting, anorexia, and weight loss in AIDS patients. Insys Therapeutics is also developing Dronabinol Oral Solution, a liquid formulation of dronabinol.

Annual Reports

Frequently Asked Questions

What is Insys Therapeutics Inc's ticker?

Insys Therapeutics Inc's ticker is INSY

What exchange is Insys Therapeutics Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Insys Therapeutics Inc's headquarters?

They are based in Chandler, Arizona

How many employees does Insys Therapeutics Inc have?

There are 201-500 employees working at Insys Therapeutics Inc

What is Insys Therapeutics Inc's website?

It is http://www.insysrx.com/

What type of sector is Insys Therapeutics Inc?

Insys Therapeutics Inc is in the Healthcare sector

What type of industry is Insys Therapeutics Inc?

Insys Therapeutics Inc is in the Biotechnology industry

Who are Insys Therapeutics Inc's peers and competitors?

The following five companies are Insys Therapeutics Inc's industry peers:

- Baudax Bio, Inc.

- Celcuity

- Cellectis S.A.

- Optical Cable

- Dicerna Pharmaceuticals